In recent years the pharmaceutical sector has seen a number of the market blockbusting drugs lose patent protection and open these drugs up for generic protection.  Furthermore, the number of drugs being rejected and never making it to market has created a focused view on the manner in which drugs are discovered, placed through trail and then produced in order to ensure safety and maintain profits.

In the healthcare sector IT systems are critical to the safety of all and the traditionally paper-based solutions are now failing to meet today’s needs and regulations.

As with any sector, automating processes increases efficiency but with the pharmaceutical and healthcare sector this has added impetus due to the regulatory requirements (i.e. CFR21 Part 11) facing such organisations. Xarus can provide a range of services that enable a more efficient discover, trial, production and distribution operation, speeding up the time to market for successful drugs.